Trial Profile
A Randomised Controlled Trial of Combinating an Immune Modulator Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2023
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Fingolimod (Primary)
- Indications Stroke
- Focus Proof of concept; Therapeutic Use
- Acronyms FAMTAIS
- 27 Mar 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 10 Nov 2016 New trial record